| |
| |
|
| Insider
Information: |
Young David |
| Relationship: |
|
| City: |
Columbia |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
79,387 |
|
|
Indirect Shares
|
70,940 |
|
|
| Direct
Value |
$17,862 |
|
|
|
Indirect Value
|
$13,571 |
|
|
| Total
Shares |
150,327 |
|
|
| Total
Value |
$31,433 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-6.0
|
0.0
|
| Percentage
Gain/Loss : |
 -32.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Questcor Pharmaceuticals Inc |
QCOR |
Chief Scientific Officer |
2014-08-14 |
0 |
2013-03-07 |
10,625 |
Premium* |
|
|
Processa Pharmaceuticals, Inc. |
PCSA |
|
2024-02-07 |
79,387 |
2024-02-07 |
60,315 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-02-24 |
4 |
OE |
$4.54 |
$27,240 |
D/D |
6,000 |
111,351 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-03-14 |
4 |
OE |
$4.54 |
$27,240 |
D/D |
6,000 |
117,741 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-06-24 |
4 |
OE |
$4.54 |
$27,240 |
D/D |
6,000 |
117,741 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2010-11-02 |
4 |
OE |
$0.43 |
$31,444 |
D/D |
28,125 |
36,422 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
President & CEO |
• • • |
2023-06-12 |
4 |
B |
$0.80 |
$32,000 |
D/D |
40,000 |
470,424 |
0.01 |
% |
|
| PCSA |
Processa Pharmaceuticals,... |
Pres. Research & Development |
• • • |
2023-10-10 |
4 |
A |
$0.24 |
$34,080 |
D/D |
142,000 |
612,424 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-03-03 |
4 |
OE |
$5.77 |
$34,620 |
D/D |
6,000 |
111,741 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Pres. Research & Development |
• • • |
2023-10-12 |
4 |
A |
$0.29 |
$45,030 |
D/D |
155,277 |
767,701 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2012-08-10 |
4 |
OE |
$1.47 |
$46,319 |
D/D |
10,625 |
13,903 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Pres. Research & Development |
• • – |
2024-02-06 |
4 |
B |
$2.53 |
$50,504 |
D/D |
20,000 |
58,387 |
0.01 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Pres. Research & Development |
• • – |
2024-02-07 |
4 |
B |
$2.45 |
$51,526 |
D/D |
21,000 |
79,387 |
0.01 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Chief Executive Officer |
• • • |
2021-06-23 |
4 |
B |
$7.67 |
$76,716 |
D/D |
10,000 |
345,190 |
3.23 |
% |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2013-11-19 |
4 |
OE |
$5.77 |
$86,550 |
D/D |
15,000 |
89,603 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-01-29 |
4 |
OE |
$5.77 |
$150,800 |
D/D |
20,000 |
111,145 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2011-08-15 |
4 |
S |
$32.00 |
$194,944 |
D/D |
(6,092) |
8,002 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2011-08-05 |
4 |
S |
$28.50 |
$285,000 |
D/D |
(10,000) |
8,402 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2011-08-12 |
4 |
S |
$32.00 |
$297,856 |
D/D |
(9,308) |
8,302 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2012-04-27 |
4 |
OE |
$4.54 |
$317,800 |
D/D |
70,000 |
73,278 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2011-10-31 |
4 |
OE |
$4.54 |
$340,500 |
D/D |
75,000 |
83,002 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2010-11-02 |
4 |
S |
$12.33 |
$346,891 |
D/D |
(28,125) |
8,297 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-03-14 |
4 |
S |
$61.78 |
$373,669 |
D/D |
(6,000) |
111,741 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-01-24 |
4 |
S |
$64.38 |
$386,294 |
D/D |
(6,000) |
91,145 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2013-11-13 |
4 |
OE |
$4.54 |
$454,000 |
D/D |
100,000 |
174,603 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-02-24 |
4 |
S |
$78.88 |
$473,290 |
D/D |
(6,000) |
105,351 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2014-06-24 |
4 |
S |
$91.96 |
$551,764 |
D/D |
(6,000) |
117,741 |
0 |
- |
|
54 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
